In the time it takes to read this piece, 30 Chinese men and women will die from heart disease. This staggering statistic means that as Asia continues to witness astonishing growth and development, Asians will increasingly wrestle with the disease. Heart disease is already the number one killer in China and India, and is fast on the rise throughout Southeast Asia, where the World Health Organization reports that cardiovascular diseases accounts for 27% of all deaths.
Mary Poppins was wrong; it’s not a spoonful of sugar that helps the medicine go down, it’s a spoonful of “big data,” and it will make healthcare expenditure more palatable in the Doctor’s Office of 2050. As big data, telehealth, and the cloud come together, we will see healthcare reap the efficiency rewards of a decentralized approach.
The development of conformal coating technology was driven to a large degree by the military and aerospace industries. While conformal coatings are mostly used on populated, printed wiring boards (PWBs), they are also used to protect components such as transistors, diodes, rectifiers, resistors, integrated circuits (ICs), and hybrid circuits including multi-chip modules (MCMs) and chip on board (COB).
The migration of smart subsystems into products at every level of operation represents a true fusion of the electronic and mechanical, representing the next, and possibly the culmination of, the industrial revolution. However, the integration of sense, motion, and logic into all portions of a system also brings with it new (or old in new clothing) challenges in power management.
According to an article from Computer Weekly, mobility and accessibility are the driving factors behind the adoption of ruggedized tablets over computers on wheels (CoWs) in healthcare settings. As mentioned in a previous blog post, CoWs have several downsides...
I tried hard to find a topic other than the coming medical device excise tax to write about, however, either my brain didn’t have any more room to fit another topic or there’s just not that much else going on in the medical device industry (which is much less likely). I was also hesitant to write the column because, unlike with the web, there is a period of time that passes from the moment I complete the column until the time it is published and mailed where the content is out of my hands while outside forces can wreak havoc on the topic and the timing of its appearance.
I have yet to hop aboard the smart phone bandwagon. While I realize there are a number of benefits, to me, it still seems like a pricey way to access my e-mail and Facebook when I’m not home in front of my desktop computer. And really, I still don’t yet need that ability.
Design and manufacturing engineers strive to develop high-quality devices in a budget-conscious and timely manner. The problem is that a variety of challenges occur in the design and assembly processes that can present functionality issues of the finished device.
In 2011, the medical device market in the US was estimated to be $105.8 billion - a market based largely upon clinical and surgical interventions administered in hospitals. However, the design and manufacture of medical devices is undergoing paradigm shifts in cost and utility, motivated largely by miniaturization, which has revolutionized consumer products.
Every medical device manufacturer accepts that in the current regulatory environment, with the Food and Drug Administration (FDA) demanding complete life cycle traceability of every product, accurate labeling is a necessity. Yet the reality is far from satisfactory: many companies have issues with label quality, not knowing what was printed, discarding pre-printed stock and needing to dispose of labeled products; whilst product recalls and field instances are endemic not due to the failure of research and development or manufacturing processes but inaccurate labeling information.
Healthcare providers should welcome the recently proposed ruling by the Food and Drug Administration (FDA), which states that medical devices distributed in the United States will be required to carry a Unique Device Identifier (UDI) as part of labeling and packaging.
Through the pre-coffee haze of your morning ritual you notice a red dot blinking on the bathroom mirror that is fogged with shower steam, “oh dear” you think “I wonder what’s wrong.” You press the illuminated mirror and a message pops up letting you know your body temperature is elevated. A menu of options appears on your mirror, and you select ‘speak to health worker.’ Welcome to the doctor’s office of 2050: your home.
As medical device companies engage in the business challenge of creating new products in a highly regulated market, two key factors slow innovation. First, companies too often rely on FDA-required compliance systems to drive innovation. These systems are focused on enabling the automated maintenance of design controls, and do not ensure creativity or good business outcomes for a business.
The globalization of design, sourcing, manufacturing, and sales of Medical Technology (Med-Tech) has created opportunities and challenges for the entire ecosystem. To assess the impact of globalization and outsourcing in the Medical Technology Industry, Axendia conducted a survey research of 125 Medical Technology Industry Executives representing 89 different companies across 16 countries. This article provides a summary of the project’s research report entitled, “Walking the Global Tightrope: Balancing the Risks and Rewards of Med-Tech Globalization.”
In today’s manufacturing environment, ergonomics and repetitive motion injuries are major issues that every business must address to insure production levels remain at expected levels and employee injuries remain as infrequent as possible. Although many of the hand assembly processes have been replaced with automated equipment over the past 20 years, there is still a surprising number of manual operations still required for many applications.